Objective: Preexposure prophylaxis (PrEP) offers a promising new approach to HIV prevention.
This systematic review and meta-analysis evaluated the evidence for use of oral PrEP …

Background HIV enhances human papillomavirus (HPV)-induced carcinogenesis. However,
the contribution of HIV to cervical cancer burden at a population level has not been …

Background Antiretroviral drugs have been shown to reduce risk of mother‐to‐child
transmission of human immunodeficiency virus (HIV) and are also widely used for post‐exposure …

Background Effective national and global HIV responses require a significant expansion of
HIV testing and counselling (HTC) to expand access to prevention and care. Facility-based …

HIV self-testing (HIVST) is a potential strategy to overcome disparities in access to and uptake
of HIV testing, particularly among key populations (KP). A literature review was conducted …

Introduction Several approaches have been taken to reduce pre‐antiretroviral therapy (ART)
losses between HIV testing and ART initiation in low‐ and middle‐income countries, but a …

Methods This review followed guidance from the Cochrane Collaboration [27] and the PRISMA
statement for the reporting of systematic reviews and meta‐analyses. The review protocol …

Background We update a previous systematic review to inform new World Health Organization
HIV self-testing (HIVST) recommendations. We compared the effects of HIVST to standard …

Daily oral pre-exposure prophylaxis (PrEP) is the use of antiretroviral drugs by HIV-negative
people to prevent HIV infection. WHO released new guidelines in 2015 recommending …

Inadequate uptake of testing for human immunodeficiency virus (HIV) remains a primary
bottleneck toward universal access to treatment and care, and is an obstacle to realizing the …